Suppr超能文献

含钠与微量钠静脉注射免疫球蛋白制剂治疗川崎病急性期儿童的比较。

Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase.

机构信息

Department of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.

Department of Pediatrics, Fujita Health University, Aichi, Japan.

出版信息

Eur J Pediatr. 2021 Nov;180(11):3279-3286. doi: 10.1007/s00431-021-04096-x. Epub 2021 May 10.

Abstract

Kawasaki disease (KD) is an acute systemic vasculitis that most commonly causes acquired cardiac disease in children in developed countries. The most highly recommended treatment for KD is 2 g/kg intravenous immunoglobulin (IVIG). There are two types of IVIG, sodium-containing (high-Na) and sodium-trace (low-Na) preparations. However, few studies have compared the effects of these two preparations for superiority. The purpose of this study was to compare outcomes between high and low-Na IVIG preparations in KD children using a national inpatient database in Japan. We used the Diagnostic Procedure Combination database to identify KD patients treated with IVIG between 2010 and 2017. We identified those receiving high and low-Na preparations of IVIG as an initial treatment. Outcomes included proportion of coronary artery abnormalities (CAA), IVIG resistance, adverse effects, length of stay, and medical cost. Propensity score-matched analyses were conducted to compare the outcomes between the two groups. Instrumental variable analyses were performed to confirm the results. We identified 42,345 patients with KD. There were significant differences in proportions of CAA (2.8% vs. 3.2%; p = 0.031) and IVIG resistance (17% vs. 18%, p = 0.001) between the two groups. However, there were no significant differences in length of stay or medical cost. The instrumental variable analysis confirmed the same results as the propensity score analysis.Conclusion: The present study suggests that high-Na IVIG is potentially effective for reducing the proportion of CAA in KD patients. Prospective studies are warranted to confirm the effectiveness observed in this study. What is Known: • For treatments of Kawasaki Disease in acute phase, intravenous immunoglobulin have been the most recommended to reduce fever early and prevent complications of coronary artery abnormalities. There are two types of IVIG preparations, sodium-containing IVIG and sodium-trace IVIG. However, few studies have performed comparisons to determine which preparation of IVIG is superior. What is New: • The present findings suggest that high-Na IVIG is associated with reductions in the proportions of CAAs and IVIG resistance in KD patients.

摘要

川崎病(KD)是一种急性全身性血管炎,在发达国家,它最常导致儿童获得性心脏病。KD 最推荐的治疗方法是 2 克/千克静脉注射免疫球蛋白(IVIG)。IVIG 有两种类型,含钠(高钠)和含钠痕量(低钠)制剂。然而,很少有研究比较这两种制剂的优势。本研究旨在使用日本全国住院患者数据库比较 KD 儿童中高钠和低钠 IVIG 制剂的疗效。我们使用诊断程序组合数据库确定 2010 年至 2017 年间接受 IVIG 治疗的 KD 患者。我们确定了接受 IVIG 高钠和低钠制剂初始治疗的患者。结局包括冠状动脉异常(CAA)的比例、IVIG 抵抗、不良反应、住院时间和医疗费用。进行倾向评分匹配分析比较两组结局。进行工具变量分析以确认结果。我们确定了 42345 例 KD 患者。两组 CAA 比例(2.8%比 3.2%;p=0.031)和 IVIG 抵抗(17%比 18%;p=0.001)有显著差异。然而,住院时间或医疗费用无显著差异。工具变量分析证实了倾向评分分析的相同结果。结论:本研究表明,高钠 IVIG 可能有效降低 KD 患者 CAA 的比例。需要进行前瞻性研究以证实本研究观察到的有效性。已知:• 在川崎病的急性期治疗中,静脉注射免疫球蛋白是最推荐的,以早期退热并预防冠状动脉异常并发症。IVIG 有两种制剂,含钠 IVIG 和含钠痕量 IVIG。然而,很少有研究进行比较以确定哪种 IVIG 制剂更优越。新发现:• 本研究结果表明,高钠 IVIG 与 KD 患者 CAA 比例降低和 IVIG 抵抗有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验